{"id":"https://openalex.org/W2022555151","doi":"https://doi.org/10.4161/cbt.19594","title":"Antiangiogenic agents in the management of non-small cell lung cancer","display_name":"Antiangiogenic agents in the management of non-small cell lung cancer","publication_year":2012,"publication_date":"2012-03-01","ids":{"openalex":"https://openalex.org/W2022555151","doi":"https://doi.org/10.4161/cbt.19594","mag":"2022555151","pmid":"https://pubmed.ncbi.nlm.nih.gov/22481432","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3367715"},"language":"en","primary_location":{"id":"doi:10.4161/cbt.19594","doi":"https://doi.org/10.4161/cbt.19594","is_oa":true,"landing_page_url":"https://doi.org/10.4161/cbt.19594","pdf_url":"https://www.tandfonline.com/doi/pdf/10.4161/cbt.19594?needAccess=true&role=button","source":{"id":"https://openalex.org/S169029442","display_name":"Cancer Biology & Therapy","issn_l":"1538-4047","issn":["1538-4047","1555-8576"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Biology & Therapy","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.tandfonline.com/doi/pdf/10.4161/cbt.19594?needAccess=true&role=button","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5056098854","display_name":"Charu Aggarwal","orcid":"https://orcid.org/0000-0002-3181-9460","observed_orcids":["https://orcid.org/0000-0002-3181-9460"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charu Aggarwal","raw_affiliation_strings":["Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA","Department of Medicine","Division of Hematology/Oncology","Philadelphia, PA USA","University of Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I79576946"]},{"raw_affiliation_string":"Department of Medicine","institution_ids":[]},{"raw_affiliation_string":"Division of Hematology/Oncology","institution_ids":[]},{"raw_affiliation_string":"Philadelphia, PA USA","institution_ids":[]},{"raw_affiliation_string":"University of Pennsylvania","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087234749","display_name":"Neeta Somaiah","orcid":"https://orcid.org/0000-0002-0146-7732","observed_orcids":["https://orcid.org/0000-0002-0146-7732"]},"institutions":[{"id":"https://openalex.org/I153297377","display_name":"Medical University of South Carolina","ror":"https://ror.org/012jban78","country_code":"US","type":"education","lineage":["https://openalex.org/I153297377"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Neeta Somaiah","raw_affiliation_strings":["Division of Hematology/Oncology; Department of Medicine; Medical University of South Carolina; Charleston, SC USA","Charleston, SC USA","Department of Medicine","Division of Hematology/Oncology","Medical University of South Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology/Oncology; Department of Medicine; Medical University of South Carolina; Charleston, SC USA","institution_ids":["https://openalex.org/I153297377"]},{"raw_affiliation_string":"Charleston, SC USA","institution_ids":[]},{"raw_affiliation_string":"Department of Medicine","institution_ids":[]},{"raw_affiliation_string":"Division of Hematology/Oncology","institution_ids":[]},{"raw_affiliation_string":"Medical University of South Carolina","institution_ids":["https://openalex.org/I153297377"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5102964486","display_name":"George R. Simon","orcid":"https://orcid.org/0000-0002-3894-0773","observed_orcids":["https://orcid.org/0000-0002-3894-0773"]},"institutions":[{"id":"https://openalex.org/I153297377","display_name":"Medical University of South Carolina","ror":"https://ror.org/012jban78","country_code":"US","type":"education","lineage":["https://openalex.org/I153297377"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"George Simon","raw_affiliation_strings":["Division of Hematology/Oncology; Department of Medicine; Medical University of South Carolina; Charleston, SC USA","Charleston, SC USA","Department of Medicine","Division of Hematology/Oncology","Medical University of South Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology/Oncology; Department of Medicine; Medical University of South Carolina; Charleston, SC USA","institution_ids":["https://openalex.org/I153297377"]},{"raw_affiliation_string":"Charleston, SC USA","institution_ids":[]},{"raw_affiliation_string":"Department of Medicine","institution_ids":[]},{"raw_affiliation_string":"Division of Hematology/Oncology","institution_ids":[]},{"raw_affiliation_string":"Medical University of South Carolina","institution_ids":["https://openalex.org/I153297377"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5102964486"],"corresponding_institution_ids":["https://openalex.org/I153297377"],"apc_list":{"value":2710,"currency":"EUR","value_usd":2970},"apc_paid":null,"fwci":0.7874,"has_fulltext":true,"cited_by_count":69,"citation_normalized_percentile":{"value":0.623357,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"13","issue":"5","first_page":"247","last_page":"263"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.73580002784729,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.73580002784729,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.2409999966621399,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.0066999997943639755,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.8989999890327454},{"id":"https://openalex.org/keywords/anti-angiogenic-therapy","display_name":"anti-angiogenic therapy","score":0.9750000238418579},{"id":"https://openalex.org/keywords/angiogenesis-inhibitors","display_name":"angiogenesis inhibitors","score":0.8629999756813049},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/vascular-endothelial-growth-factor","display_name":"vascular endothelial growth factor","score":0.6449999809265137},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.972000002861023},{"id":"https://openalex.org/keywords/vandetanib","display_name":"vandetanib","score":0.890999972820282},{"id":"https://openalex.org/keywords/sorafenib","display_name":"sorafenib","score":1.0},{"id":"https://openalex.org/keywords/vascular-disrupting-agents","display_name":"vascular disrupting agents","score":0.8510000109672546},{"id":"https://openalex.org/keywords/ramucirumab","display_name":"ramucirumab","score":0.9869999885559082},{"id":"https://openalex.org/keywords/aflibercept","display_name":"aflibercept","score":0.9940000176429749},{"id":"https://openalex.org/keywords/cediranib","display_name":"cediranib","score":0.9380000233650208},{"id":"https://openalex.org/keywords/sunitinib","display_name":"sunitinib","score":0.8429999947547913},{"id":"https://openalex.org/keywords/pazopanib","display_name":"pazopanib","score":0.9919999837875366},{"id":"https://openalex.org/keywords/brivanib","display_name":"brivanib","score":0.9259999990463257},{"id":"https://openalex.org/keywords/axitinib","display_name":"axitinib","score":0.8529999852180481},{"id":"https://openalex.org/keywords/carboplatin","display_name":"carboplatin","score":0.6800000071525574},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.9879999756813049},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.6850000023841858},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9480000138282776}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8657650947570801},{"id":"https://openalex.org/C2780333294","wikidata":"https://www.wikidata.org/wiki/Q7914515","display_name":"Vandetanib","level":4,"score":0.8439038991928101},{"id":"https://openalex.org/C2778439243","wikidata":"https://www.wikidata.org/wiki/Q7157043","display_name":"Pazopanib","level":4,"score":0.816489577293396},{"id":"https://openalex.org/C2776539811","wikidata":"https://www.wikidata.org/wiki/Q4830631","display_name":"Axitinib","level":4,"score":0.8163393139839172},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.7973911166191101},{"id":"https://openalex.org/C2779490328","wikidata":"https://www.wikidata.org/wiki/Q417542","display_name":"Sunitinib","level":3,"score":0.7611908912658691},{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.6927477121353149},{"id":"https://openalex.org/C2780171596","wikidata":"https://www.wikidata.org/wiki/Q15149723","display_name":"Nintedanib","level":4,"score":0.6854473352432251},{"id":"https://openalex.org/C2779551604","wikidata":"https://www.wikidata.org/wiki/Q7290345","display_name":"Ramucirumab","level":3,"score":0.6354650259017944},{"id":"https://openalex.org/C2778749236","wikidata":"https://www.wikidata.org/wiki/Q4689286","display_name":"Aflibercept","level":4,"score":0.6140398979187012},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.594703197479248},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5925823450088501},{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.5824912786483765},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.5710887908935547},{"id":"https://openalex.org/C2776248978","wikidata":"https://www.wikidata.org/wiki/Q3891664","display_name":"Regorafenib","level":4,"score":0.5200511813163757},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.504358172416687},{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.5000331401824951},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4833538234233856},{"id":"https://openalex.org/C2776820818","wikidata":"https://www.wikidata.org/wiki/Q7699074","display_name":"Temsirolimus","level":5,"score":0.44209355115890503},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.41062402725219727},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.35872483253479004},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.12303215265274048},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.11629077792167664},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.11489075422286987},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.09048745036125183},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.07928091287612915},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C183713625","wikidata":"https://www.wikidata.org/wiki/Q5282002","display_name":"Discovery and development of mTOR inhibitors","level":4,"score":0.0},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.0},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C2778341716","wikidata":"https://www.wikidata.org/wiki/Q2290446","display_name":"Idiopathic pulmonary fibrosis","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000098","qualifier_name":"blood supply","is_major_topic":true},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000098","qualifier_name":"blood supply","is_major_topic":true},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009389","descriptor_name":"Neovascularization, Pathologic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017322","descriptor_name":"Clinical Trials, Phase II as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017326","descriptor_name":"Clinical Trials, Phase III as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.4161/cbt.19594","doi":"https://doi.org/10.4161/cbt.19594","is_oa":true,"landing_page_url":"https://doi.org/10.4161/cbt.19594","pdf_url":"https://www.tandfonline.com/doi/pdf/10.4161/cbt.19594?needAccess=true&role=button","source":{"id":"https://openalex.org/S169029442","display_name":"Cancer Biology & Therapy","issn_l":"1538-4047","issn":["1538-4047","1555-8576"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Biology & Therapy","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2583456","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/articles/PMC3367715","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3367715","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3367715","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Biol Ther","raw_type":"Text"},{"id":"pmid:22481432","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22481432","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer biology & therapy","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.4161/cbt.19594","doi":"https://doi.org/10.4161/cbt.19594","is_oa":true,"landing_page_url":"https://doi.org/10.4161/cbt.19594","pdf_url":"https://www.tandfonline.com/doi/pdf/10.4161/cbt.19594?needAccess=true&role=button","source":{"id":"https://openalex.org/S169029442","display_name":"Cancer Biology & Therapy","issn_l":"1538-4047","issn":["1538-4047","1555-8576"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Biology & Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320306257","display_name":"Boehringer Ingelheim","ror":"https://ror.org/05kffp613"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2022555151.pdf","grobid_xml":"https://content.openalex.org/works/W2022555151.grobid-xml"},"referenced_works_count":94,"referenced_works":["https://openalex.org/W70034951","https://openalex.org/W202471535","https://openalex.org/W922724308","https://openalex.org/W1963194685","https://openalex.org/W1966162777","https://openalex.org/W1967587727","https://openalex.org/W1970261786","https://openalex.org/W1978111504","https://openalex.org/W1979538859","https://openalex.org/W1986716191","https://openalex.org/W1989109072","https://openalex.org/W1996515934","https://openalex.org/W1998462298","https://openalex.org/W2000112605","https://openalex.org/W2008552099","https://openalex.org/W2010898909","https://openalex.org/W2012945281","https://openalex.org/W2014075906","https://openalex.org/W2021558699","https://openalex.org/W2025712796","https://openalex.org/W2029169364","https://openalex.org/W2033008724","https://openalex.org/W2034483653","https://openalex.org/W2040935952","https://openalex.org/W2057147918","https://openalex.org/W2059499441","https://openalex.org/W2064926421","https://openalex.org/W2074238578","https://openalex.org/W2077125884","https://openalex.org/W2084415993","https://openalex.org/W2089756110","https://openalex.org/W2093116780","https://openalex.org/W2095729959","https://openalex.org/W2096514095","https://openalex.org/W2097373408","https://openalex.org/W2099022883","https://openalex.org/W2100785570","https://openalex.org/W2102056525","https://openalex.org/W2102590541","https://openalex.org/W2102996502","https://openalex.org/W2105246037","https://openalex.org/W2105464202","https://openalex.org/W2109240520","https://openalex.org/W2111080882","https://openalex.org/W2111512928","https://openalex.org/W2112940666","https://openalex.org/W2113652101","https://openalex.org/W2114940128","https://openalex.org/W2115078104","https://openalex.org/W2115330744","https://openalex.org/W2118471405","https://openalex.org/W2118559000","https://openalex.org/W2123172787","https://openalex.org/W2124464299","https://openalex.org/W2126310082","https://openalex.org/W2130105793","https://openalex.org/W2132365366","https://openalex.org/W2139675556","https://openalex.org/W2140765540","https://openalex.org/W2143214527","https://openalex.org/W2143550524","https://openalex.org/W2144026946","https://openalex.org/W2144660856","https://openalex.org/W2145835533","https://openalex.org/W2151046016","https://openalex.org/W2152262604","https://openalex.org/W2153297361","https://openalex.org/W2154581953","https://openalex.org/W2155338842","https://openalex.org/W2156438240","https://openalex.org/W2156800473","https://openalex.org/W2157099922","https://openalex.org/W2158734599","https://openalex.org/W2159370421","https://openalex.org/W2159711942","https://openalex.org/W2167798736","https://openalex.org/W2169976781","https://openalex.org/W2170024262","https://openalex.org/W2212360244","https://openalex.org/W2229860909","https://openalex.org/W2240346141","https://openalex.org/W2249498798","https://openalex.org/W2261037082","https://openalex.org/W2268972469","https://openalex.org/W2339460051","https://openalex.org/W2433114596","https://openalex.org/W2471428377","https://openalex.org/W2540110531","https://openalex.org/W2563376698","https://openalex.org/W2589833400","https://openalex.org/W3009541188","https://openalex.org/W3089753619","https://openalex.org/W4247899189","https://openalex.org/W4251192558"],"related_works":["https://openalex.org/W2064795528","https://openalex.org/W2099791513","https://openalex.org/W2808479470","https://openalex.org/W2016548318","https://openalex.org/W2084213940","https://openalex.org/W2039480487","https://openalex.org/W2068644483","https://openalex.org/W2050790659","https://openalex.org/W2005361820","https://openalex.org/W3145231710"],"abstract_inverted_index":{"Several":[0],"therapies":[1],"targeting":[2],"angiogenesis":[3],"are":[4,101],"currently":[5,34],"in":[6,42,68],"development":[7],"for":[8,27,36],"non-small":[9],"cell":[10],"lung":[11],"cancer":[12],"(NSCLC).":[13],"This":[14],"review":[15],"discusses":[16],"results":[17],"of":[18,39,75,123],"recent":[19],"clinical":[20,152],"trials":[21,51,64,74,100,140],"evaluating":[22,52],"chemotherapy":[23,55,97],"plus":[24,54],"antiangiogenic":[25,106,146],"therapy":[26],"NSCLC.":[28],"Bevacizumab,":[29],"an":[30],"anti-VEGF":[31],"antibody,":[32],"is":[33],"approved":[35],"the":[37,76,85],"treatment":[38],"advanced":[40],"NSCLC":[41],"combination":[43],"with":[44,96],"carboplatin":[45],"and":[46,82,84,120,136],"paclitaxel.":[47],"Completed":[48],"phase":[49,129,138],"III":[50,73,139],"bevacizumab":[53],"have":[56,126],"shown":[57,127],"prolonged":[58],"progression-free":[59],"survival;":[60],"however,":[61],"not":[62],"all":[63],"showed":[65],"significant":[66],"improvement":[67],"overall":[69],"survival":[70],"(OS).":[71],"Phase":[72],"tyrosine":[77],"kinase":[78],"inhibitors":[79],"(TKIs)":[80],"vandetanib":[81],"sorafenib":[83],"vascular":[86],"disrupting":[87],"agent":[88],"ASA404":[89],"also":[90],"failed":[91],"to":[92],"improve":[93],"OS":[94],"compared":[95],"alone.":[98],"Clinical":[99],"ongoing":[102,137],"involving":[103],"several":[104,122],"new":[105],"therapies,":[107],"including":[108],"ramucirumab,":[109],"aflibercept,":[110],"cediranib,":[111],"BIBF":[112],"1120,":[113],"sunitinib,":[114],"pazopanib,":[115],"brivanib,":[116],"ABT-869,":[117],"axitinib,":[118],"ABT-751,":[119],"NPI-2358;":[121],"these":[124,144],"agents":[125,147],"promising":[128],"I/II":[130],"results.":[131],"Results":[132],"from":[133],"recently":[134],"completed":[135],"will":[141,148],"determine":[142],"if":[143],"newer":[145],"be":[149],"incorporated":[150],"into":[151],"practice.":[153]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":9},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":9},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}